BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Green DA, Murphy WG, Uttley WS. Haemolytic uraemic syndrome: prognostic factors. Clin Lab Haematol 2000;22:11-4. [PMID: 10762298 DOI: 10.1046/j.1365-2257.2000.00272.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Tsai M, Kita A, Leach J, Rounsevell R, Huang JN, Moake J, Ware RE, Fletcher DA, Lam WA. In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J Clin Invest 2012;122:408-18. [PMID: 22156199 DOI: 10.1172/JCI58753] [Cited by in Crossref: 180] [Cited by in F6Publishing: 109] [Article Influence: 16.4] [Reference Citation Analysis]
2 Green D. P1 blood group and haemolytic uraemic syndrome: Correspondence. Clinical & Laboratory Haematology 2000;22:55-55. [DOI: 10.1046/j.1365-2257.2000.00258.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
3 Krogvold L, Henrichsen T, Bjerre A, Brackman D, Dollner H, Gudmundsdottir H, Syversen G, Næss PA, Bangstad HJ. Clinical aspects of a nationwide epidemic of severe haemolytic uremic syndrome (HUS) in children. Scand J Trauma Resusc Emerg Med 2011;19:44. [PMID: 21798000 DOI: 10.1186/1757-7241-19-44] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
4 Cooling L. Blood Groups in Infection and Host Susceptibility. Clin Microbiol Rev 2015;28:801-70. [PMID: 26085552 DOI: 10.1128/CMR.00109-14] [Cited by in Crossref: 206] [Cited by in F6Publishing: 103] [Article Influence: 29.4] [Reference Citation Analysis]
5 López EL, Contrini MM, Glatstein E, Ayala SG, Santoro R, Ezcurra G, Teplitz E, Matsumoto Y, Sato H, Sakai K, Katsuura Y, Hoshide S, Morita T, Harning R, Brookman S. An epidemiologic surveillance of Shiga-like toxin-producing Escherichia coli infection in Argentinean children: risk factors and serum Shiga-like toxin 2 values. Pediatr Infect Dis J 2012;31:20-4. [PMID: 21829137 DOI: 10.1097/INF.0b013e31822ea6cf] [Cited by in Crossref: 33] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
6 Rothschild B. Trochanteric area pain, the result of a quartet of bursal inflammation. World J Orthop 2013; 4(3): 100-102 [PMID: 23878774 DOI: 10.5312/wjo.v4.i3.100] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
7 Myers DR, Sakurai Y, Tran R, Ahn B, Hardy ET, Mannino R, Kita A, Tsai M, Lam WA. Endothelialized microfluidics for studying microvascular interactions in hematologic diseases. J Vis Exp 2012:3958. [PMID: 22760254 DOI: 10.3791/3958] [Cited by in Crossref: 20] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
8 Miyagawa A, Kasuya MCZ, Hatanaka K. Elimination Filter for Verotoxins —Highly Adsorbing by Glycoconjugate Polymer—. Chem Lett 2008;37:438-9. [DOI: 10.1246/cl.2008.438] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Wong CS, Mooney JC, Brandt JR, Staples AO, Jelacic S, Boster DR, Watkins SL, Tarr PI. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis. Clin Infect Dis. 2012;55:33-41. [PMID: 22431799 DOI: 10.1093/cid/cis299] [Cited by in Crossref: 166] [Cited by in F6Publishing: 140] [Article Influence: 16.6] [Reference Citation Analysis]